Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07250139 · ClinicalTrials.gov registry record · NA
Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation
A NA study of Ptosis, Eyelid and Blepharoplasty, sponsored by Osheru.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07250139: Recruiting NA study of Ptosis, Eyelid and Blepharoplasty, sponsored by Osheru.
NCT07250139 is a NA study of Ptosis, Eyelid and Blepharoplasty that is actively recruiting participants, run by Osheru. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07250139, a NA study of Ptosis, Eyelid and Blepharoplasty, is actively recruiting participants, sponsored by Osheru.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two surgery techniques used for upper eyelid (eyelift) surgery: traditional surgery and a newer method called Ziplyft (a non-powered, hand-held clamp). This study will use a "split-face" design, meaning one eyelid will be treated with the traditional surgery method and the other with Ziplyft, allowing a direct side-by-side comparison. The objectives of the study are to compare Ziplyft treatment vs. traditional surgery by evaluating bruising, wound closure and incision, surgery case time, and subject/surgeon surveys.
Primary Outcome
The surgeon will record the surgical case times for Ziplyft and standard blepharoplasty. For the Ziplyft side of the participant's face the surgical case time begins when the Ziplyft device touches the patient lid and ends 1 min after adhesive is applied as that is when it has cured. For the standard blepharoplasty side of the participant's face the surgical case time begins as the blade begins its first cut and ends once ointment has been applied.
Conditions Studied
Interventions
- DEVICE Ziplyft Device
- OTHER Comparator Arm: Standard Blepharoplasty
Study Locations (1)
North Carolina
- New Century Ophthalmology - Oxford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT07250139 shows while recruiting
NCT07250139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Ptosis, Eyelid appearing as the primary indexed condition, and to 2 interventions - of which Ziplyft Device is the first listed.
NCT07250139 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07250139 about?
NCT07250139 is a clinical study titled "Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation". This study will compare two surgery techniques used for upper eyelid (eyelift) surgery: traditional surgery and a newer method called Ziplyft (a non-powered, hand-held clamp). This study will use a "split-face" design, meaning one eyelid will be treated with the traditional surgery method and the ot...
What is the current status of trial NCT07250139?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-08. Estimated completion is 2026-09-30.
What conditions does trial NCT07250139 study?
This clinical trial studies the following conditions: Ptosis, Eyelid, Blepharoplasty, Dermatochalasis of Upper Eyelid.
What interventions are being tested in trial NCT07250139?
The interventions under investigation include: Ziplyft Device (DEVICE), Comparator Arm: Standard Blepharoplasty (OTHER).
Who is sponsoring clinical trial NCT07250139?
This trial is sponsored by Osheru, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07250139 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ptosis, Eyelid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07250139's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI